검색어: proteinudskillelse (덴마크어 - 영어)

i den første undersøgelse vedrørende nyresygdom var aprovel mere effektivt end placebo til at reducere risikoen for at udvikle nyreskade som målt ved proteinudskillelse.
in the first kidney disease study, aprovel was more effective than placebo at reducing the risk of developing kidney damage as measured by protein excretion.

i den første undersøgelse vedrørende nyresygdom var irbesartan winthrop mere effektivt end placebo til at reducere risikoen for at udvikle nyreskade som målt ved proteinudskillelse.
in the first kidney disease study, irbesartan winthrop was more effective than placebo at reducing the risk of developing kidney damage as measured by protein excretion.

i den første undersøgelse vedrørende nyresygdom var irbesartan bms mere effektivt end placebo til at reducere risikoen for at udvikle nyreskade, som målt ved proteinudskillelse.
in the first kidney disease study, irbesartan bms was more effective than placebo at reducing the risk of developing kidney damage as measured by protein excretion.

i den første undersøgelse vedrørende nyresygdom (irma 2) var aprovel væsentligt bedre end placebo til at reducere risikoen for at udvikle nyreskade som målt ved proteinudskillelse.
in the first kidney disease study (irma 2) , aprovel was significantly better than placebo at reducing the risk of developing kidney damage as measured by protein excretion.

i den første undersøgelse vedrørende nyresygdom (irma 2) var irbesartan bms væsentligt bedre end placebo til at reducere risikoen for at udvikle nyreskade, som målt ved proteinudskillelse.
in the first kidney disease study (irma 2) , irbesartan bms was significantly better than placebo at reducing the risk of developing kidney damage as measured by protein excretion.

i den første undersøgelse vedrørende nyresygdom (irma 2) var irbesartan winthrop væsentligt bedre end placebo til at reducere risikoen for at udvikle nyreskade, som målt ved proteinudskillelse.
in the first kidney disease study (irma 2) , irbesartan winthrop was significantly better than placebo at reducing the risk of developing kidney damage as measured by protein excretion.

i den første undersøgelse vedrørende nyresygdom var aprovel mere effektivt end placebo til at reducere risikoen for at udvikle nyreskader, hvilket blev målt ved proteinudskillelsen.
in the first kidney disease study, aprovel was more effective than placebo at reducing the risk of developing kidney damage as measured by protein excretion.